Paracetamol efficacy and safety in children: the first 40 years

Related Experiment Videos

N Cranswick1, D Coghlan

  • 1Clinical pharmacologist, Royal Children's Hospital, Parkville, Victoria, 3052, Australia.

Insights

Paracetamol (acetaminophen) is the leading choice for managing fever and pain in children due to its safety and efficacy. While generally safe, overdose can cause liver damage, necessitating prompt treatment.

Area of Science:

  • Pediatric Pharmacology
  • Pain Management
  • Fever Treatment

Background:

  • Paracetamol (acetaminophen) is a widely used medication for children's fever and pain.
  • It is considered safe and well-tolerated at recommended pediatric doses.
  • Fever alone doesn't require treatment, but paracetamol alleviates associated discomfort and pain.

Purpose of the Study:

  • To review the role and dosing of paracetamol in pediatric pain and fever management.
  • To discuss the safety profile, including overdose risks and management.
  • To compare paracetamol with other analgesics/antipyretics like aspirin and ibuprofen.

Main Methods:

  • Literature review of pediatric dosing guidelines for paracetamol.
  • Analysis of paracetamol's efficacy in mild, moderate, and severe pain.
  • Examination of overdose toxicity, antidotes, and monitoring tools (Rumack-Matthew Nomogram).

Main Results:

  • Pediatric paracetamol dosing ranges globally from 10-15 mg/kg every 4 hours.
  • It provides effective analgesia and antipyresis, with additive effects in severe pain.
  • Overdose (>10x recommended dose) is hepatotoxic; early treatment is effective. Chronic overdose risk exists above 140 mg/kg/day.
  • Aspirin use has declined; ibuprofen is a second-line option.

Conclusions:

  • Paracetamol remains the first-line treatment for pediatric analgesia and antipyresis.
  • Appropriate dosing is crucial to maximize efficacy and minimize hepatotoxicity risks.
  • Effective antidotes and nomograms improve overdose management outcomes in children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...